Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes
- PMID: 29961358
- PMCID: PMC6032529
- DOI: 10.1176/appi.ajp.2018.17060688
Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes
Abstract
Objective: Adults with serious mental illness and comorbid alcohol dependence are at high risk for both high utilization of crisis-driven health care services and criminal justice involvement. Evidence-based medication-assisted treatment (MAT) for alcohol dependence may reduce both crisis service utilization and criminal recidivism. The authors estimated the effect of MAT on behavioral health treatment utilization and criminal justice outcomes for this population.
Method: Relevant administrative data were merged from several public agencies in Connecticut for 5,743 adults ≥18 years old who had schizophrenia spectrum disorder, bipolar disorder, or major depressive disorder comorbid with moderate to severe alcohol dependence and who were incarcerated for at least one night during the study window (2002-2009). Longitudinal multivariable regression models were used to estimate the effect of MAT compared with other outpatient substance abuse treatments on inpatient mental health and substance abuse hospitalizations, emergency department visits, criminal convictions, and incarcerations.
Results: MAT was associated with significant improvements in clinical outcomes in the 12 months following initiation compared with non-MAT comparison treatment, including greater reductions in mental health hospitalization and emergency department visits and greater improvements in psychotropic medication adherence. No benefits of MAT were found for most criminal justice outcomes, except for significant reductions in felony convictions among adults with bipolar disorder.
Conclusions: MAT is underused for treating alcohol dependence, especially among adults with serious mental illness. These results suggest that MAT can have important benefits for clinical outcomes in this population. More research is needed to improve its use in this patient population as well as to address barriers to its availability.
Keywords: Alcohol Abuse; Mood Disorders-Bipolar; Mood Disorders-Unipolar; Prisons; Schizophrenia.
Conflict of interest statement
Dr. Lin reports no conflicts. Dr. Frisman reports no conflicts.
Comment in
-
Medication-Assisted Treatment for Alcohol Use Disorder: Hope for Incarcerated Patients and for Our Communities.Am J Psychiatry. 2018 Jul 1;175(7):596-597. doi: 10.1176/appi.ajp.2018.18040445. Am J Psychiatry. 2018. PMID: 29961365 No abstract available.
-
Use of Disulfiram for Treatment of Alcohol Addiction in Patients With Psychotic Illness.Am J Psychiatry. 2019 Jan 1;176(1):80-81. doi: 10.1176/appi.ajp.2018.18070795. Am J Psychiatry. 2019. PMID: 30848944 No abstract available.
References
-
- Negrete JC. Clinical aspects of substance abuse in persons with schizophrenia. Can J Psychiatry. 2003;48:14–21. - PubMed
-
- Margolese HC, Malchy L, Negrete JC, et al. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res. 2004;67:157–166. - PubMed
-
- Turkington A, Mulholland CC, Rushe TM, et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry. 2009;195:242–248. - PubMed
-
- Opsal A, Clausen T, Kristensen O, et al. Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up. Acta Psychiatr Scand. 2011;124:198–204. - PubMed
-
- Kavanagh DJ, McGrath J, Saunders JB, et al. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs. 2002;62:743–755. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical